Prognostic implications of stress hyperglycemia ratio in patients with myocardial infarction with nonobstructive coronary arteries

References

• Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990–2015. J Am Coll Cardiol. 2017;70(1):1–25.
   PubMed Web of Science ®Google Scholar
• Niccoli G, Scalone G, Crea F. Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management. Eur Heart J. 2015;36(8):475–481.
   PubMed Web of Science ®Google Scholar
• Pasupathy S, Air T, Dreyer RP, et al. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015;131(10):861–870.
   PubMed Web of Science ®Google Scholar
• Agewall S, Beltrame JF, Reynolds HR, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017;38:143–153.
   PubMed Web of Science ®Google Scholar
• Tamis-Holland JE, Jneid H, Reynolds HR, On behalf of the American Heart Association Interventional Cardiovascular Care Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139(18):e891–e908.
   PubMed Web of Science ®Google Scholar
• Planer D, Mehran R, Ohman EM, et al. Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the acute catheterization and urgent intervention triage strategy trial. Circ Cardiovasc Interven. 2014;7(3):285–293.
   PubMed Web of Science ®Google Scholar
• Andersson HB, Pedersen F, Engstrøm T, et al. Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease. Eur Heart J. 2018;39(2):102–110.
   PubMed Web of Science ®Google Scholar
• Gao S, Ma W, Huang S, et al. Sex-Specific clinical characteristics and Long-Term outcomes in patients with myocardial infarction with non-obstructive coronary arteries. Front Cardiovasc Med. 2021;8:670401.
   PubMedGoogle Scholar
• Ciliberti G, Coiro S, Tritto I, et al. Predictors of poor clinical outcomes in patients with acute myocardial infarction and non-obstructed coronary arteries (MINOCA). Int J Cardiol. 2018;267:41–45.
   PubMed Web of Science ®Google Scholar
• Pelliccia F, Pasceri V, Niccoli G, et al. Predictors of mortality in myocardial infarction and nonobstructed coronary arteries: a systematic review and meta-regression. Am J Med. 2020;133(1):73–83.e4.
   PubMed Web of Science ®Google Scholar
• Pasupathy S, Lindahl B, Litwin P, et al. Survival in patients with suspected myocardial infarction with nonobstructive coronary arteries: a comprehensive systematic review and meta-analysis from the MINOCA Global Collaboration. Circ Cardiovasc Qual Outcomes. 2021;14:e007880.
   PubMed Web of Science ®Google Scholar
• Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798–1807.
   PubMed Web of Science ®Google Scholar
• Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355(9206):773–778.
   PubMed Web of Science ®Google Scholar
• Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008;117:1610–1619.
   PubMed Web of Science ®Google Scholar
• Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patient with and without recognized diabetes. Circulation. 2005;111(23):3078–3086.
   PubMed Web of Science ®Google Scholar
• Kim EJ, Jeong MH, Kim JH, et al. Clinical impact of admission hyperglycemia on in-hospital mortality in acute myocardial infarction patients. Int J Cardiol. 2017;236:9–15.
   PubMed Web of Science ®Google Scholar
• Paolisso P, Foà A, Bergamaschi L, et al. Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA. Cardiovasc Diabetol. 2021;20(1):192.
   PubMed Web of Science ®Google Scholar
• Roberts GW, Quinn SJ, Valentine N, et al. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100(12):4490–4497.
   PubMed Web of Science ®Google Scholar
• Lee TF, Drake SM, Roberts GW, et al. Relative hyperglycemia is an independent determinant of in-hospital mortality in patients with critical illness. Crit Care Med. 2020;48:e115–e122.
   PubMed Web of Science ®Google Scholar
• Nathan DM, Kuenen J, Borg R, for the A1c-Derived Average Glucose (ADAG) Study Group, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473–1478.
   PubMed Web of Science ®Google Scholar
• Xia Z, Gu T, Zhao Z, et al. The stress hyperglycemia ratio, a novel index of relative hyperglycemia, predicts short-term mortality in critically ill patients after esophagectomy. J Gastrointest Oncol. 2022;13(1):56–66.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang Z, Xu F, et al. Effects of stress hyperglycemia on Short-Term prognosis of patients without diabetes mellitus in coronary care unit. Front Cardiovasc Med. 2021;8:683932.
   PubMedGoogle Scholar
• Yang Y, Kim TH, Yoon KH, et al. The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention. Int J Cardiol. 2017;241:57–63.
   PubMed Web of Science ®Google Scholar
• Lee TF, Burt MG, Heilbronn LK, et al. Relative hyperglycemia is associated with complications following an acute myocardial infarction: a post-hoc analysis of HI-5 data. Cardiovasc Diabetol. 2017;16(1):157.
   PubMedGoogle Scholar
• Marenzi G, Cosentino N, Milazzo V, et al. Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction: a prospective study. Diabetes Care. 2018;41(4):847–853.
   PubMed Web of Science ®Google Scholar
• Gao S, Liu Q, Ding X, et al. Predictive value of the acute-to-chronic glycemic ratio for in-hospital outcomes in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Angiology. 2020;71(1):38–47.
   PubMed Web of Science ®Google Scholar
• Xu W, Yang YM, Zhu J, et al. Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: insights from a multi-center observational study. Cardiovasc Diabetol. 2022;21(1):48.
   PubMed Web of Science ®Google Scholar
• Yang J, Zheng Y, Li C, et al. The impact of the stress hyperglycemia ratio on short-term and long-term poor prognosis in patients with acute coronary syndrome: insight from a large cohort study in Asia. Diabetes Care. 2022;45(4):947–956.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264.
   PubMed Web of Science ®Google Scholar
• Hicks KA, Mahaffey KW, Mehran R, Standardized Data Collection for Cardiovascular Trials Initiative (SCTI), et al. 2017 Cardiovascular and stroke endpoint definitions for clinical trials. J Am Coll Cardiol. 2018;71(9):1021–1034.
   PubMed Web of Science ®Google Scholar
• Ma H, Bandos AI, Rockette HE, et al. On use of partial area under the ROC curve for evaluation of diagnostic performance. Statist Med. 2013;32(20):3449–3458.
   PubMed Web of Science ®Google Scholar
• Delong ER, Delong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics. 1988;44(3):837–845.
   PubMed Web of Science ®Google Scholar
• Yuan T, Yang T, Chen H, et al. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol. 2019;20:247–260.
   PubMed Web of Science ®Google Scholar
• Lemkes BA, Hermanides J, Devries JH, et al. Hyperglycemia: a prothrombotic factor? J Thromb Haemost. 2010;8(8):1663–1669.
   PubMed Web of Science ®Google Scholar
• Meza CA, La Favor JD, Kim DH, et al. Endothelial dysfunction: is there a hyperglycemia-induced imbalance of NOX and NOS? IJMS. 2019;20(15):3775.
   Google Scholar
• Paneni F, Beckman JA, Creager MA, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34(31):2436–2443.
   PubMed Web of Science ®Google Scholar
• Tran HV, Gore JM, Darling CE, et al. Hyperglycemia and risk of ventricular tachycardia among patients hospitalized with acute myocardial infarction. Cardiovasc Diabetol. 2018;17(1):136.
   PubMedGoogle Scholar
• Cheung NW, Wong VW, McLean M. The hyperglycemia: intensive insulin infusion in infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29(4):765–770.
   PubMed Web of Science ®Google Scholar
• Malmberg K, Rydén L, Wedel H, for the DIGAMI 2 Investigators, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26(7):650–661.
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Miller ME, Genuth S, ACCORD Study Group, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364(9):818–828.
   PubMed Web of Science ®Google Scholar
• Duckworth W, Abraira C, Moritz T, VADT Investigators, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–139.
   PubMed Web of Science ®Google Scholar
• Marfella R, Sasso FC, Cacciapuoti F, et al. Tight glycemic control may increase regenerative potential of myocardium during acute infarction. J Clin Endocrinol Metab. 2012;97:933–942.
   PubMed Web of Science ®Google Scholar
• Sasso FC, Rinaldi L, Lascar N, et al. Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes. J Diabetes Res. 2018;2018:3106056.
   PubMed Web of Science ®Google Scholar
• Caturano A, Galiero R, Pafundi PC, et al. Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence. Diabetes Res Clin Pract. 2021;178:108959.
   PubMed Web of Science ®Google Scholar